“Fighting Cancer: It’s All We Do.” ™. Restoring Quality of Life And Managing Side Effects Ulka Vaishampayan M.D. Chair, GU Multidisciplinary team Associate.

Slides:



Advertisements
Similar presentations
Advanced breast cancer
Advertisements

GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Castrate-resistant prostate cancer (CRPC)
Oncology The study of cancer. What is cancer? Any malignant growth or tumor caused by abnormal and uncontrolled cell division May be a tumor but it doesn’t.
British Association of Urological Surgeons Metastatic Prostate Cancer Guidelines.
Continuous versus Intermittent Androgen Deprivation Therapy for Prostate Cancer Robert Dreicer, M.D., M.S., FACP, FASCO Chair Dept of Solid Tumor Oncology.
Oncology and Palliative Care: Promoting the Comfort and Cure Model Parag Bharadwaj, MD FAAHPM.
First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.
AM Report 9/11/09 Prostate Cancer Julia Rauch. Disease Burden ~220,000 men were diagnosed with prostate cancer in 2007 ~1/6 men will receive the disagnosis.
Diet and Health Chapter 11. Cancer Facts  US men have a 1 in 2 lifetime risk  US women have a 1 in 3 lifetime risk  1,220,000 new malignant cancer.
Advances in the Management of Skeletal Related Events/Bone Metastases in Prostate Cancer Robert Dreicer, M.D., M.S., FACP, FASCO Chair Dept of Solid Tumor.
Dietary Supplements.  Intended to supplement the diet  Contains one or more ingredients  Intended to be taken by mouth (but is not a food)  Labeled.
A Lifetime of Quality Care That’s Convenient & Complete Dietary Supplements (Part 3) Robert Grimshaw, MD FACP A Lifetime of Quality Care That’s Convenient.
What You Need to Know for Better Bone Health. A quick lesson about bones: Why healthy bones matter The healthier your bones The more active you can be.
John Doyle, Jon Hood, Jimmy Svab. Lung Cancer is the uncontrolled growth of abnormal cells. Abnormal cells do not develop into healthy tissue. Instead.
GNC Mega Men: Maximum Nutrition GNC Mega Men: Maximum Nutrition Dietary supplement “Mega Men® Maximum Nutrition is more than just a multivitamin, it features.
Osteoporosis Dr. Lauren Phillips Sugar Land Women’s Health.
Treatment. Bisphosphonates Promotes bone formation and decreases bone resorption Mechanism of Action First line treatment for osteoporosis in both men.
CRC-1 The Need for 3rd-Line Therapy in Non-Small Cell Lung Cancer Frances A. Shepherd, MD Scott Taylor Chair in Lung Cancer Research Princess Margaret.
Taking Supplements for Nutrition VS. Eating Whole Foods to Obtain Nutrients “Let food be thy medicine and medicine be thy food”-Hippocrates.
Midlife Women’s Health Margery Gass, MD, NCMP Executive Director The North American Menopause Society Consultant, Cleveland Clinic Center for Specialized.
Annual General Practitioner Study Day 2012 Men’s Health Workshop Managing side effects of male cancer therapy Dr Conleth Murphy, Consultant Medical Oncologist.
Women's Health Study: Low-Dose Aspirin in Primary Prevention Presented at American College of Cardiology Scientific Sessions 2005 Presented by Dr. Dr.
1Stopeck A et al. Proc SABCS 2010;Abstract P
Renal Safety of Zoledronic Acid in Patients With Breast Cancer.
HOW TO CONTROL CANCER Putting Science into Practice.
Linda Snetselaar, PhD, RD Professor Interim Chair of the Department of Community and Behavioral Health College of Public Health University of Iowa.
The Effect of Zoledronic Acid (ZOL) on Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole:
Hormonal Replacement Therapy for postmenopausal females: To give or not to give? Amna B. Buttar, MD, MS Assistant Professor of Clinical Medicine Indiana.
Terminology of Neoplasms and Tumors  Neoplasm - new growth  Tumor - swelling or neoplasm  Leukemia - malignant disease of bone marrow  Hematoma -
More Palatable Nutrition Guidelines Ron Krauss, MD Senior Scientist, Head of Molecular Medicine Lawrence Berkeley National Laboratory University of California.
Prostate Cancer By: Kurt Rishel.
Cancer 101: A Cancer Education and Training Program for [Target Population] Date Location Presented by: Presenter 1 Presenter 2.
 Identify different options of cancer therapy.  Most cancers are treated with a combination of approaches.
Hormone Refractory Prostate Cancer A Regulatory Perspective of End Points to Measure Safety and Efficacy of Drugs Hormone Refractory Prostate Cancer Bhupinder.
Medication Options H ealthPLACE/HOPE Program COPYRIGHT © 2002 Highmark Inc. All Rights Reserved. These materials may not be copied or otherwise reproduced.
Some Current Issues in the Management of Prostate Cancer Suman Chatterjee MD.
PROSTATE CANCER PROSTATE CANCER What you should know about Prostate Cancer:  Prostate cancer is the most common type of cancer found in American men,
Prostate Cancer By: Bryan Trae Frankie. Description of the Disease Prostate Cancer is a form of cancer that develops in the prostate, a gland in the male.
PROSTATE CANCER: RADIATION APPROACHES for advanced disease
Core Benefit/Risk (CR)
Ref: Craig W; ‘Nutrition and Wellness’ Wahlqvist M; ‘Food and Nutrition’ 2002 Prepared by Sibilla Johnson, B.Sc. Nutrition Unit 14.
Treatment Multiple Myeloma. Symptomatic/progressive myeloma: Systemic therapy - to control progression of myeloma Supportive care - to prevent serious.
A Comparison of Fulvestrant 500 mg with Anastrozole as First-line Treatment for Advanced Breast Cancer: Follow-up Analysis from the FIRST Study Robertson.
CD-1 Second-line Chemotherapy for Hormone Refractory Prostate Cancer Disease Background Nicholas J. Vogelzang, MD Director Nevada Cancer Institute CD-1.
REGULATORY HISTORY of ZOMETA and AREDIA JAW OSTEONECROSIS (ONJ) Oncologic Drug Advisory Committee March 4, 2005 Nancy S. Scher, M.D.
Weekly Alendronate Safe and Effective at Increasing Bone Mineral Density in HIV-Infected Persons on Antiretroviral Therapy Slideset on: McComsey GA, Kendall.
Life after Prostate Cancer and its treatment Mr Sanjeev Pathak Consultant Urological Surgeon and Cancer Lead Doncaster and Bassetlaw NHS Trust 12 th March.
3. How do you intend to resolve the issue?. Approach to the patient Assure patient’s safety! Talk the patient out of committing suicide – Remind him that.
Carcinoma of the prostate. INTRODUCTION Prostate cancer is the most common cancer diagnosed and is the second leading cause of cancer death in men in.
Bone Health Secondary Breast Cancer
Casodex 50mg - Prostate Cancer Drug Casodex 50 mg is a prostate cancer drug used in hormonal therapy to treat the same. It reduces production of androgen.
Osteoporosis Risk Factors... Are You at Risk? Osteoporosis is a disease that leads to decreased bone density and leaves the bones weak and easily fractured.
Matthew Raymond Smith, MD, PhD Professor of Medicine Harvard Medical School Program Director, Genitourinary Oncology Massachusetts General Hospital Cancer.
Vitamin Supplements For Women. Vitamins are very important for the body because they provide energy for metabolism, help produce hormones, strong bones,
Overview of Nutrition Related Diseases
Managing Side Effects and Looking After Yourself On & Off Treatment Jane Tinsley Clinical Nurse Specialist Linda Boyne Haematology Nurse Counsellor.
Opener #9 Are you eating healthier than you did 2 weeks ago (before the nutrition unit)? Explain.    
STAMPEDE: Docetaxel Significantly Improves Survival in Men With Hormone-Naive Prostate Cancer CCO Independent Conference Highlights of the 2015 ASCO Annual.
PHEN Clinical Trials Rally
Unit 34 Care of the client with Gastric Carcinoma
Medication for osteoporosis
Alena Kreychman Xofigo.
Skeletal Morbidity in Men with Prostate Cancer: Quality-of-Life Considerations throughout the Continuum of Care  Fred Saad, Carl Olsson, Claude C. Schulman 
Jacques Irani  European Urology Supplements 
Bisphosphonates Can Prevent Skeletal Complications of Malignant Bone Disease from Prostate Cancer and Renal Cell Carcinoma  Fred Saad  European Urology.
Bob Djavan  European Urology Supplements 
New Models of Care in Idiopathic Pulmonary Fibrosis
Maintaining bone health while on ADT for Prostate Cancer
Uncovering the Right Sequence
Presentation transcript:

“Fighting Cancer: It’s All We Do.” ™

Restoring Quality of Life And Managing Side Effects Ulka Vaishampayan M.D. Chair, GU Multidisciplinary team Associate Professor Of Medicine Detroit Medical Center Wayne State University/ Karmanos Cancer Institute, Detroit MI.

Metastatic Prostate Cancer Common site of spread- bones Incurable, likely terminal condition Morbidity significant as it can lead to bone pain,cord compression, fractures, urinary obstruction etc. Initial therapy with hormones which is effective, but temporary

Metastatic disease: hormone therapy Hormone therapy questions: When to start? Continuous vs intermittent Which kind: Lupron/Zoladex with casodex or casodex alone (50 mg daily) or high dose casodex 150 mg daily Should we stop treatment when it stops working? What are the risks?

Common Complications of Hormone Therapy –Fatigue –Metabolic syndrome- high blood sugar, high cholesterol –Increased risk of heart problems in people who have heart disease –Hot flashes –Impotence –Osteoporosis –Gynecomastia and breast tenderness –Mood swings –Liver toxicity –Diarrhea, nausea

Strategies to address side effects of hormone therapy Hormone therapy works by suppressing the male hormone/testosterone levels. Fighting the side effects: -Increased Awareness -Stay active - Healthy diet -Ask for medication therapy for hot flashes if bothersome. -Consider intermittent hormone therapy if feasible -Monitor cholesterol, blood sugars periodically.

Supportive Care in Advanced Prostate Cancer Bone strengthening therapy Radiation Pain control therapies Chemotherapy/novel agents

Zometa vs. Placebo in Hormone Refractory Metastatic Prostate Cancer Berruti et al, JNCI 2003

Bisphosphonates for Treatment of Bone Metastasis Frequency of skeletal complications due to bone metastasis Median time to first skeletal-related event compared with placebo Zoledronic acid Placebo days P=0.011 Not reached Days After Start of Therapy Patients Without Event (%) 33% 44%

Dietary factors Lycopene: A minimum of 2 servings (1 cup) per week of tomato sauce can reduce the risk of development and progression of prostate cancer. Cruciferous vegetables: at least five servings per week can decrease the risk of developing prostate cancer by 20%. Green Tea may have possible protective effects A large study showed that too much calcium (over 2000mg daily) can increase metastatic prostate cancer risk fivefold compared with those consuming <500 mg daily- Health Professionals Follow Up study

Dietary factors Vitamins within the recommended daily intake are recommended Overdosage of vitamins maybe potentially harmful Male smokers study in Finland showed that Vitamin E supplementation decreased the incidence of prostate cancer by 32% and the mortality related to prostate cancer by 41%. Beta carotene (Vit A) increased risk of lung cancer Finasteride/Proscar prevented prostate cancer and reduced the risk by 25% Selenium and Vit E trial completed and no benefit noted.

Systemic Therapy in Treatment of Prostate Cancer –Discuss use of systemic therapy in metastatic prostate cancer to a} Prolong life b}Palliation or symptom control –In locally advanced prostate cancer, the goal is to improve cure rate and keep long term toxicity to a minimum

Development of Hormonal Escape Prostate Cancer. London, England: Times Mirror International Publishers Ltd;1996:143. Deprive androgen Cell numbers Time Androgen-independent cells take over Responsive Dependent Independent

Metastatic Disease Therapy in hormone refractory disease Supportive care and palliation options: Currently approved –Chemotherapy –Bisphosphonate therapy –Radioisotope therapy

“Fighting Cancer: It’s All We Do.” ™